293 related articles for article (PubMed ID: 9309091)
1. Combined modality therapy of gastric cancer.
Karpeh MS; Kelsen DP
Surg Oncol Clin N Am; 1997 Oct; 6(4):741-7. PubMed ID: 9309091
[TBL] [Abstract][Full Text] [Related]
2. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
3. [Preoperative (neoadjuvant) chemotherapy in multimodality treatment concept of stomach carcinoma].
Meyer HJ; Jähne J; Wilke H; Pichlmayr R
Zentralbl Chir; 1995; 120(2):128-34. PubMed ID: 7709664
[TBL] [Abstract][Full Text] [Related]
4. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
[TBL] [Abstract][Full Text] [Related]
5. [New insights in the adjuvant treatment of gastric cancer].
Jansen EP; Boot H; Cats A; van Coevorden F; Zoetmulder FA; Verheij M
Ned Tijdschr Geneeskd; 2004 Dec; 148(51):2529-34. PubMed ID: 15636473
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant therapy for resectable gastric adenocarcinoma: preoperative and postoperative chemotherapy trials.
Leach SD; Lowy AM; Mansfield PF; Ajani JA
J Infus Chemother; 1995; 5(3):104-11. PubMed ID: 8528966
[TBL] [Abstract][Full Text] [Related]
7. Surgery for gastric cancer: the American view.
Brennan MF; Karpeh MS
Semin Oncol; 1996 Jun; 23(3):352-9. PubMed ID: 8658219
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy for locally advanced gastric adenocarcinoma.
Alexander HR; Grem JL; Pass HI; Hamilton M; McAtee N; Fraker DL; Allegra CJ
Oncology (Williston Park); 1993 May; 7(5):37-42; discussion 42-4, 49-50, 53. PubMed ID: 8512781
[TBL] [Abstract][Full Text] [Related]
9. Rationale for the current surgical management of gastric adenocarcinoma.
Dalton RR; Eisenberg BL
Oncology (Williston Park); 1994 Jul; 8(7):99-105; discussion 105-7. PubMed ID: 7917844
[TBL] [Abstract][Full Text] [Related]
10. Progress in the management of gastric cancer.
Karpeh MS; Brennan MF
Curr Opin Gen Surg; 1994; ():125-30. PubMed ID: 7583945
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.
Fu S; Lu JJ; Zhang Q; Yang Z; Peng L; Xiong F
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1488-94. PubMed ID: 18538489
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
Ajani JA; Winter K; Okawara GS; Donohue JH; Pisters PW; Crane CH; Greskovich JF; Anne PR; Bradley JD; Willett C; Rich TA
J Clin Oncol; 2006 Aug; 24(24):3953-8. PubMed ID: 16921048
[TBL] [Abstract][Full Text] [Related]
13. [Curative resection of advanced gastric cancer responding to preoperative chemotherapy--a case report].
Kobayashi M; Kasakura Y; Fujii M; Mochizuki F; Kochi M; Eguchi T; Imai S
Gan To Kagaku Ryoho; 2001 Apr; 28(4):527-30. PubMed ID: 11329789
[TBL] [Abstract][Full Text] [Related]
14. Results of immunochemo-surgery for gastric carcinoma.
Kim JP; Yu HJ; Lee JH
Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
[TBL] [Abstract][Full Text] [Related]
15. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.
Yu W
Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532
[TBL] [Abstract][Full Text] [Related]
16. Individualized surgical strategies for cancer of the esophagogastric junction.
Stein HJ; Feith M; Siewert JR
Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
[TBL] [Abstract][Full Text] [Related]
18. A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study).
Kodera Y; Ito S; Mochizuki Y; Kondo K; Koshikawa K; Suzuki N; Kojima H; Kojima T; Matsui T; Takase T; Tsuboi K; Fujiwara M; Nakao A;
Eur J Surg Oncol; 2009 Nov; 35(11):1158-63. PubMed ID: 19328643
[TBL] [Abstract][Full Text] [Related]
19. Role of surgery in the patients with stage I and II primary gastric lymphoma.
Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
[TBL] [Abstract][Full Text] [Related]
20. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A
J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
